Alison Holland

Executive General Manager, Digital and Decentralized Solutions

Alison (Ali) Holland is Head of Decentralized Clinical Trials at Medable and is chartered to design and expand the end-to-end capabilities needed to partially or fully virtualize clinical studies, building on the commitment to reduce clinical trial times by 50%.

Ali has over 20 years of experience in a variety of leadership roles, including Feasibility Head and Six Sigma Black Belt at Covance, and Business Head and global General Manager at Roche/Genentech in one of their therapeutic area business groups.

Having been engaged in over 300 studies across Biotechs, Pharma, and all geographies, Ali brings an incomparable level of insight and technical excellence on the matter of operational needs for sites and patients.